X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Gastrointestinal Therapeutics Companies

This report lists the top Gastrointestinal Therapeutics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Gastrointestinal Therapeutics industry.

Gastrointestinal Therapeutics Top Companies

  1. Abbvie Inc.

  2. AstraZeneca

  3. Takeda Pharmaceutical Company Limited

  4. Bausch Health Companies Inc. (Salix Pharmaceuticals Inc.)

  5. Johnson & Johnson(Janssen Global Services LLC)

*Disclaimer: Top companies sorted in no particular order

 Gastrointestinal Therapeutics Market Major Players

Gastrointestinal Therapeutics Market Concentration

Gastrointestinal Therapeutics Market Concentration

Gastrointestinal Therapeutics Company List

                              • Abbott

                              • Abbvie Inc.

                              • AstraZeneca

                              • Bayer AG

                              • GSK plc

                              • Johnson & Johnson(Janssen Global Services LLC)

                              • Pfizer Inc.

                              • Takeda Pharmaceutical Company Limited

                              • Bausch Health Companies Inc. (Salix Pharmaceuticals Inc.)

                              • Boehringer Ingelheim International GmbH

                              • Cipla Inc.

                              • Sebela Pharmaceuticals

                          • MARKET OPPORTUNITIES AND FUTURE TRENDS


                          Specific to Gastrointestinal Therapeutics Market
                          Need More Details On Market Players And Competitors?
                          Download Sample

                          Gastrointestinal Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)